Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C12H13O4.Mg |
| Molecular Weight | 466.7634 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].COC1=CC=C(\C(C)=C/C([O-])=O)C(OC)=C1.COC2=CC=C(\C(C)=C/C([O-])=O)C(OC)=C2
InChI
InChIKey=NRMWCJKNPLZLMY-HIGYRTBYSA-L
InChI=1S/2C12H14O4.Mg/c2*1-8(6-12(13)14)10-5-4-9(15-2)7-11(10)16-3;/h2*4-7H,1-3H3,(H,13,14);/q;;+2/p-2/b2*8-6-;
| Molecular Formula | C12H13O4 |
| Molecular Weight | 221.2292 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
| Molecular Formula | Mg |
| Molecular Weight | 24.305 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dimecrotic acid is a choleretic agent with spasmolytic properties. It is obtained by reaction of resorcinol with acetoacetate to give 4-methyl-7-hydroxycoumarin. It is indicated for the treatment of hepato-digestive insufficiency and its manifestations. It shouldn’t be used in case of blockage of bile ducts, severe liver failure and severe renal impairment. Diarrhea may be associated with high doses of dimecrotic acid.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:12:27 GMT 2025
by
admin
on
Mon Mar 31 22:12:27 GMT 2025
|
| Record UNII |
1IZ92DEM5B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000087491
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
236347
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | RxNorm | ||
|
m4496
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
1IZ92DEM5B
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
247-407-1
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
6446007
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
SUB01737MIG
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
54283-65-7
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
PRIMARY | |||
|
26011-83-6
Created by
admin on Mon Mar 31 22:12:27 GMT 2025 , Edited by admin on Mon Mar 31 22:12:27 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |